Sonnet Biotherapeutics Holdings Inc (SONN) Financials

$1.26

$-1.84 (-59.35%)

As on 02-Dec-2025 16:29EDT

Market cap

$9 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

2.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Operating Revenue	1.00	0.02	0.15	0.15	0.35	0.35
Cost of Revenue	--	0.08	0.08	0.08	0.09	0.09
Gross Profit	--	0.02	0.07	0.15	0.26	-21.09
Operating Expenses	16.84	11.87	18.94	18.94	30.02	8.58
Operating Profit (EBIT)	-15.84	-11.85	-18.79	-18.79	-29.67	-29.67
Other Income	--	--	--	--	--	--
Profit before Tax	-15.79	-7.44	-18.83	-18.83	-29.72	-29.72
Provision for Tax	-0.22	--	0.04	0.04	0.05	0.05
Profit after Tax (Net Income)	-16.11	-7.44	-18.83	-18.83	-29.77	-29.77
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-29.72	-29.72

Liabilities ($ Mln)	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Shareholder's Funds	10.79	-0.49	-0.23	-0.23	-2.54	-2.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.05	0.13	0.13	0.20	0.20
Current Liabilities	4.10	3.21	5.52	5.52	8.16	8.16
Total Liabilities	14.88	2.77	5.43	5.43	5.83	5.83

Assets ($ Mln)	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Non-Current Assets	0.54	0.65	0.69	0.69	0.42	0.42
Current Assets	14.34	2.12	4.74	4.74	5.41	5.41
Total Assets	14.88	2.77	5.43	5.43	5.83	5.83
Total Debt*	0.05	0.13	0.20	0.20	0.26	0.26
Net Current Assets	--	-1.09	-0.79	-0.79	-2.75	-2.75

Cashflow ($ Mln)	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Cash From Operating Activities	-12.83	-8.61	-21.34	-21.34	-27.69	-27.69
Cash Flow from Investing Activities	-0.01	-0.01	--	-0.44	-0.90	-0.90
Cash from Financing Activities	26.05	6.49	21.01	21.01	4.01	4.01
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Adjusted EPS ($)	-4.06	-11.44	-4.71	-86.07	--	-1,172.22
Cash EPS ($)	-4.06	-11.31	-4.69	-85.73	--	-1,168.55
Adjusted Book Value ($)	2.72	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-3.23	-13.24	-5.34	-97.54	--	-1,090.05
Free Cash Flow per Share ($)	-3.23	-13.24	-5.45	-99.57	--	-1,125.34

Profitability Ratios	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
ROCE (%)	-307.52	3,946.07	1,634.22	1,634.22	-296.22	-296.22
ROE (%)	-312.81	2,089.93	1,362.37	1,362.37	-301.95	-301.95
ROA (%)	-182.52	-181.38	-334.52	-334.52	-171.00	-171.00
EBIT Margin (%)	--	-63,617.91	-12,687.35	-12,714.47	-8,478.34	-8,478.34
Net Margin (%)	-1,611.27	-39,929.30	-12,741.58	-12,741.58	-8,508.34	-8,508.34
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Revenue Growth (%)	52.69	-0.87	-0.58	-0.58	-0.28	-0.28
EBIT Growth (%)	--	36.95	36.79	36.66	-18.26	-18.26
Net Profit Growth (%)	-116.65	60.51	36.75	36.75	-19.07	-19.07
EPS Growth (%)	0.64	0.87	--	0.93	--	0.55
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Price / Earnings	-1.13	-0.58	-0.37	-0.03	--	0.00
Price / Book Value	1.68	-8.96	-30.80	-2.78	--	-0.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.83	-0.37	-0.26	0.08	0.09	0.09
Close Price ($)	4.58	6.69	13.92	22.96	202.40	258.72
High Price ($)	19.30	23.44	295.68	528.00	1,649.40	1,798.72
Low Price ($)	1.08	4.99	8.64	21.36	160.51	216.48
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Debt to Equity	0.00	-0.27	-0.90	-0.90	-0.10	-0.10
Short term debt to equity ratio	0.00	-0.17	-0.32	-0.65	-0.02	-0.02
Current Ratio	3.50	0.66	0.86	0.86	0.66	0.66
Quick Ratio	--	--	--	--	0.75	0.75
Interest Coverage	--	--	--	--	-727.64	-727.64

Operating Efficiency Ratios	Sep-25	Sep-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20	Dec-19
Debtors to sales (%)	--	4,091.47	532.17	532.17	204.98	204.98
Asset Turnover	0.11	0.00	0.03	0.03	0.02	0.02
Receivable days	278.35	15,184.29	1,858.16	1,858.16	748.68	748.68
Inventory Days	--	--	-3,458.69	-3,458.69	-2,809.39	-2,809.39
Payable days	--	9,635.88	16,766.15	16,766.16	16,711.41	16,711.41
Cash Conversion Cycle	--	--	-18,366.68	-18,366.68	-18,772.12	-18,772.12